Palladyne AI Corp PDYN Q1 2026 Earnings EPS Misses Estimates Shares Rise on No Revenue Report Novo Nordisk AS NVO Q1 2026 Earnings Strong EPS Beat Driven by Obesity and Diabetes Portfolio SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development SRE Q1 2026 Earnings Slight EPS Miss as Utility Performance Holds Steady HCWB Q1 2026 Earnings Significant EPS Surprise with No Product Revenue LPX Q1 2026 Earnings Massive EPS Surprise Drives Modest Stock Gains